153 related articles for article (PubMed ID: 28829509)
1. Clinical significance of PSMA, TERT and PDEF in malignant tumors of the prostate.
Situ J; Zhang H; Lu L; Li K; Hu C; Wang DJ
Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3347-3352. PubMed ID: 28829509
[TBL] [Abstract][Full Text] [Related]
2. High expression of PSM-E correlated with tumor grade in prostate cancer: a new alternatively spliced variant of prostate-specific membrane antigen.
Cao KY; Mao XP; Wang DH; Xu L; Yuan GQ; Dai SQ; Zheng BJ; Qiu SP
Prostate; 2007 Dec; 67(16):1791-800. PubMed ID: 17929272
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of prostate-specific membrane antigen (PSMA) versus a prostate-specific membrane antigen-like gene.
O'Keefe DS; Bacich DJ; Heston WD
Prostate; 2004 Feb; 58(2):200-10. PubMed ID: 14716746
[TBL] [Abstract][Full Text] [Related]
4. Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: regulation of MMP 9 by PDEF.
Johnson TR; Koul S; Kumar B; Khandrika L; Venezia S; Maroni PD; Meacham RB; Koul HK
Mol Cancer; 2010 Jun; 9():148. PubMed ID: 20550708
[TBL] [Abstract][Full Text] [Related]
5. Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients.
Schmittgen TD; Teske S; Vessella RL; True LD; Zakrajsek BA
Int J Cancer; 2003 Nov; 107(2):323-9. PubMed ID: 12949815
[TBL] [Abstract][Full Text] [Related]
6. Signatures of prostate-derived Ets factor (PDEF) in cancer.
Mahajan N
Tumour Biol; 2016 Nov; 37(11):14335-14340. PubMed ID: 27612480
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression.
Turner DP; Findlay VJ; Moussa O; Semenchenko VI; Watson PM; LaRue AC; Desouki MM; Fraig M; Watson DK
Prostate; 2011 Dec; 71(16):1723-35. PubMed ID: 21446014
[TBL] [Abstract][Full Text] [Related]
8. Prostate-derived Ets transcription factor (PDEF) is a potential prognostic marker in patients with prostate cancer.
Ghadersohi A; Sharma S; Zhang S; Azrak RG; Wilding GE; Manjili MH; Li F
Prostate; 2011 Aug; 71(11):1178-88. PubMed ID: 21656828
[TBL] [Abstract][Full Text] [Related]
9. PGC and PSMA in prostate cancer diagnosis: tissue analysis from biopsy samples.
Antunes AA; Reis ST; Leite KR; Real DM; Sousa-Canavez JM; Camara-Lopes LH; Dall'Oglio MF; Srougi M
Int Braz J Urol; 2013; 39(5):649-56. PubMed ID: 24267108
[TBL] [Abstract][Full Text] [Related]
10. Tumor metastasis suppressor functions of Ets transcription factor through integrin β3-mediated signaling pathway.
Pal M
J Cell Physiol; 2019 Nov; 234(11):20266-20274. PubMed ID: 30982973
[TBL] [Abstract][Full Text] [Related]
11. Prostate derived ETS factor (PDEF): a putative tumor metastasis suppressor.
Steffan JJ; Koul HK
Cancer Lett; 2011 Nov; 310(1):109-17. PubMed ID: 21764212
[TBL] [Abstract][Full Text] [Related]
12. PDEF in prostate cancer.
Sood AK; Kim H; Geradts J
Prostate; 2012 May; 72(6):592-6. PubMed ID: 21796651
[TBL] [Abstract][Full Text] [Related]
13. [Updated application of prostate-specific membrane antigen to the diagnosis and treatment of prostate cancer].
Tang QL; Yao MY
Zhonghua Nan Ke Xue; 2008 Jan; 14(1):79-82. PubMed ID: 18297820
[TBL] [Abstract][Full Text] [Related]
14. Construction of prostate-specific expressed recombinant plasmids with high transcriptional activity of prostate-specific membrane antigen (PSMA) promoter/enhancer.
Zeng H; Wu Q; Li H; Wei Q; Lu Y; Li X; Wang F; Zhao F; Ding Z; Yang Y
J Androl; 2005; 26(2):215-21. PubMed ID: 15713827
[TBL] [Abstract][Full Text] [Related]
15. HOXB13 regulates the prostate-derived Ets factor: implications for prostate cancer cell invasion.
Kim IJ; Kang TW; Jeong T; Kim YR; Jung C
Int J Oncol; 2014 Aug; 45(2):869-76. PubMed ID: 24898171
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells.
Tsui KH; Chung LC; Feng TH; Chang PL; Juang HH
Int J Cancer; 2012 Jun; 130(12):2812-23. PubMed ID: 21780100
[TBL] [Abstract][Full Text] [Related]
17. Differentiated prostatic antigen expression in LNCaP cells following treatment with bispecific antisense oligonucleotides directed against BCL-2 and EGFR.
Rubenstein M; Hollowell CM; Guinan P
Med Oncol; 2012 Jun; 29(2):835-41. PubMed ID: 21573974
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of PSMA expression in the prostate of mouse, dog, monkey, and human.
Aggarwal S; Ricklis RM; Williams SA; Denmeade SR
Prostate; 2006 Jun; 66(9):903-10. PubMed ID: 16496413
[TBL] [Abstract][Full Text] [Related]
19. Prostate epithelium-derived Ets transcription factor mRNA is overexpressed in human breast tumors and is a candidate breast tumor marker and a breast tumor antigen.
Ghadersohi A; Sood AK
Clin Cancer Res; 2001 Sep; 7(9):2731-8. PubMed ID: 11555586
[TBL] [Abstract][Full Text] [Related]
20. Prostate-Specific Membrane Antigen Is a Potential Antiangiogenic Target in Adrenocortical Carcinoma.
Crowley MJ; Scognamiglio T; Liu YF; Kleiman DA; Beninato T; Aronova A; Liu H; Jhanwar YS; Molina A; Tagawa ST; Bander NH; Zarnegar R; Elemento O; Fahey TJ
J Clin Endocrinol Metab; 2016 Mar; 101(3):981-7. PubMed ID: 26771706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
